Company intelligence / Profile preview

C

Melbourne, Victoria, Australia

Ownership: Private
Employees: ~32000
Development stage: Other

Overview

CSL is a leading global biotechnology company delivering biologics, plasma therapies, and vaccines. It has significant late-stage and commercial products, notably in rare disease, nephrology, and vaccines, and has reported robust positive clinical outcomes across various programs.

Therapeutic areas: NephrologyInfectious DiseasesRare DiseasesHematologyPulmonology
Modalities: BiologicProteinVaccinePlasma-derived therapySmall molecule
Industry: Pharma

Partnerships

Various governmental and global public health organizations for vaccinesAcademic and industry partners for plasma and cell therapies

Beyond the preview

Go deeper on C.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C.

Explore the full profile